Effect of pirarubicin for elderly patients with malignant lymphoma

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 4, 1998, Pages 465-470

  Aoki, S ^a   Tsukada, N ^a   Nomoto, N ^a   Maruyama, S ^a   Takahashi, M ^a   Moriyama, Y ^a   Shibata, A ^a   Aizawa, Y ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

CHOP; Elderly patients; Non Hodgkin's lymphoma; Pirarubicin; THP COP

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALAISE; MALE; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOUBLE-BLIND METHOD; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MALE; PREDNISOLONE; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0032432165     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Dantchev D., Paintrand M., Hayat M., et al.: Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and lightmicroscopy. J. Antibiotics. 32:1085-1086, 1979.
2. Hirano S,. Agata N,. Hara Y,. et al.: Effects of pirarubicin, an antitumor antibiotic on the cardiovascular system. Cancer Chemother. Pharmacol. 28:266-272, 1991.
3. O'Reilly S.E., Connors J.M., Macpherson N., et al.: Malignant lymphomas in the elderly. Clin. Geriatr. Med. 13:251-263, 1997.
4. Epelbaum. R., Haim N., Leviov M., et al.: Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma. Acta Oncol. 34:87-91, 1995.
5. Umezawa H., Takahashi Y., Kinoshita M., et al.: Tetrahydropyranyl derivatives of daunomycin and adriamycin. J. Antibiot. 32:1082-1084, 1979.
6. Ishige K, Suenaga T, Tsukuda K, Sakai T, Takagi T : THP-adriamycin-based Combination Chemotherapy in the Treatment of Non-Hodgkin's lymphomain (Japanese with English abstract). Jpn. J. Cancer Chemother. 19: 2037-2040, 1992.
7. Mitsubashi S., Ninomiya H., Shibuya A., et al.: Effect of THP-CVP therapy for elderly patients with malignant lymphoma (in Japanese with English abstract). Jpn. J. Clin. Hematol. 34: 1532-1539, 1993.
8. Temma K., Akera T., Chugan A., et al: Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart. Eur. J. Pharmacol. 234:137-181, 1993.
9. Arai N., Hara A., Kaneko H., et al: A comparative study of CHOP and COP-BLAM for elderly non-Hodgkin's lymphoma (in Japanese with English abstract). Jpn. J.Geriatr. 30: 864-867, 1993.
10. Niitsu N., Umeda M.: Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma. Int. J. Hematol. 60:71-78, 1994.
11. Caracciolo F., Petrini M., Capochiani F., et al.: Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas of the elderly. Leuk. Lymphoma 11:115-118, 1993.
12. Martelli M., Guglielmi C., Coluzzi S., et al: P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma. J. Clin. Oncol. 11: 2362-2369, 1993.